Bod hits the ground running in 2020

Bod hits the ground running in 2020

Medicinal cannabis producer Bod (ASX: BDA) is off to a strong start in 2020, reporting January as its third-largest month on record.

The group filled 373 prescriptions of its MediCabilis during the month, bringing the total number of prescriptions of its drug to 2,330 in the 12 months since launch.

"Growth in prescription numbers for January is very encouraging and we are pleased to witness this steady increase in sales," says Bod CEO Jo Patterson.

The company expects to enter into the UK this month, which should boost its prescription numbers even higher.

Bod will also launch two new products 2.5 per cent and 10 per cent MediCabilis products which will likely grab a further 32 per cent of the prescription market.

The cannabis producer says this segment is less competitive, given the lack of CBD isolate products available to patients and physicians.

"We have a great opportunity and larger sales footprint," says Patterson.

"Bod is therefore well primed to drive prescription number growth."

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

How communications technology can raise the bar on customer service, employee experience
Partner Content
From capturing feedback early to providing messages with a higher rate of cut-through, ...
Advertisement

Related Stories

Brisbane Broncos player Ryan James and Gold Coast’s BSKT launch new native food range

Brisbane Broncos player Ryan James and Gold Coast’s BSKT launch new native food range

Indigenous entrepreneur and Brisbane Broncos prop Ryan James will d...

Lewis Land steps up plans for $1.5b Harbour Shores amid Gold Coast housing crunch

Lewis Land steps up plans for $1.5b Harbour Shores amid Gold Coast housing crunch

Sovereign Islands developer Lewis Land Group has stepped up the pac...

FDA clears path for Bubs baby formula expansion in the US

FDA clears path for Bubs baby formula expansion in the US

An emergency policy in the United States to allow fast-tracked impo...

Steve McCann steps down as Crown Resorts CEO, replaced by Wynn Macau executive

Steve McCann steps down as Crown Resorts CEO, replaced by Wynn Macau executive

Following the $8.9 billion takeover of Crown Resorts by US investme...